Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID Paxlovid was associated with a 61% lower risk of hospitalization. CIDRAP

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.

Adding up the Public Health Costs of Using Coal to Make Steel - Inside Climate News A new report found connections between the American steel industry’s few remaining coal-based facilities and increased rates of asthma, cancer and premature deaths. Derek Harrison Inside Climate News

...

'Perfect storm' of distrust deepened inequalities during COVID-19 pandemic

...

Research led by University of Manchester academics, examined the attitudes of people from minoritized ethnic groups, young adults and those with long-term physical and mental health conditions toward the COVID-19 vaccination program.

Researchers found that a "perfect storm" of marginalization and experience of structural inequalities led to distrust of the COVID-19 vaccination drive—and that marginalized communities felt "left behind" by policy and decision-makers prior to and during the pandemic.

...